// SIGNALbreakthrough18 AUG 2026

Anthropic reports Claude autonomously designed de novo protein binders against 14 of 15 targets, with hit rates above typical campaigns

// WHAT IT MEANSDiscovery
How close are we?
Lab ◀TrialsSome usersEveryone
Can you use it today?
Not yet — still in the lab
Anthropic today
Lab
Pilot
Early commercial
Mass commercial

Written from the source article · ◎ = company's stated target · Not investment advice

Anthropic published a study in which Claude Opus 4.8 and a Mythos Preview model autonomously ran de novo protein-binder design campaigns, producing 1,320 designs of which 354 binders were confirmed against 14 of 15 targe

// MEMBERS.ONLY

Read the full brief

Create a free account to read the full summary, key facts and the original source for every signal.

Create a free account
Free · no card needed · Sign in
// WEEKLY.UPDATES

Every Monday: up to 5 major breakthroughs and launches, explained in plain English. Free. No account needed.

One email a week. Unsubscribe anytime.